[The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine]. 1987

H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo.

The dose limiting factors of cisplatinum are nephrotoxicity and emesis. Nephrotoxicity has been reduced by hydration but nausea and vomiting caused by cisplatinum have led to refusal of potentially curative therapy by a number of patients. The prevention of nausea and vomiting by a combination of antiemetic drugs administered to ovarian patients receiving chemotherapy inducing (cisplatinum 50mg/m2, adriamycin 300 mg/m2, cyclophosphamide 300 mg/m2 and 5FU 350 mg/m2) was studied. the combination antiemetic drugs were metoclopramide (1mg/kg), dexamethasone (10mg/m2), droperidol (1mg/m2) and diphenhydramine (20mg/body). These drugs without diphenhydramine were administered intravenously 30 minutes before and 2.5 hours, 5 hours and 7.5 hours after chemotherapy. Diphenhydramine was administered intramuscularly 30 minutes before and 5 hours after chemotherapy. No vomiting was noted in 82.6% (19/23) of cases, and no patient vomited more than four times. This combination regimen provided very good protection against cisplatinum induced emesis.

UI MeSH Term Description Entries
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004155 Diphenhydramine A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Benhydramin,Diphenylhydramin,2-Diphenylmethoxy-N,N-dimethylethylamine,Allerdryl,Benadryl,Benylin,Benzhydramine,Dimedrol,Diphenhydramine Citrate,Diphenhydramine Citrate (1:1),Diphenhydramine Hydrochloride,Diphenylhydramine,Dormin,Citrate, Diphenhydramine,Hydrochloride, Diphenhydramine
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004329 Droperidol A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) Dehydrobenzperidol,Dehidrobenzperidol,Droleptan,Inapsine
D005260 Female Females

Related Publications

H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
April 1990, American journal of clinical oncology,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
May 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
July 1992, Lancet (London, England),
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
January 1984, Cancer chemotherapy and pharmacology,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
January 1985, Cancer treatment reports,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
October 1986, European journal of cancer & clinical oncology,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
April 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
December 1986, Medicina clinica,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
June 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
H Dozono, and M Yasuda, and S Yokoyama, and S Takahashi, and K Ochiai, and M Tsuruoka, and O Morimoto, and H Sasaki, and T Arihiro, and Y Terashima
January 1991, Oncology,
Copied contents to your clipboard!